CURRICULUM VITAE Luigi Cubeddu PERSONAL - College of ...

More documents

Recommendations

Info

LUIGI X. CUBEDDU 82. Parker, E.M. and Cubeddu, L.X.: D-amphetamine (A)-induced dopamine (DA) release is not strictly dependent on newly-synthesized transmitter. FASEB, April 1986. 83. Cubeddu, L.X. and Fuenmayor, N.: Naloxone does not affect blood pressure or plasma catecholamines in patients with essential hypertension. Amer. Soc. of Hypertension, May 1986. 84. Cubeddu, L.X., Fuenmayor, N., Ferry, D.G. and Caplan, N.: Clinical pharmacokinetics of doxazosin in patients with essential hypertension. Amer. Soc. of Hypertension, May 1986. 85. Cubeddu, L.X., Fuenmayor, N., Varin, F. and Powell, J.R.: Mechanisms of blood pressure lowering effects of carvedilol. Amer. Soc. of Hypertension, May 1986. 86. Cubeddu, L.X., Aranda, J., Singh, B., Klein, M., Brachfeld, J., Freis, E., Roman, J. and Eades, T.: Verapamil vs. propranolol monotherapy in essential hypertension: A multicenter study. Amer. Soc. of Hypertension, May 1986. 87. Cubeddu, L.X. and Hoffmann, I.S.: Comparative effects of clonidine, propranolol and hydrochlorothiazide. Treatments and withdrawal on peripheral and central catecholamines in essential hypertension. Amer. Soc. of Hypertension, May 1986. 88. Cubeddu, L.X., Fuenmayor, N., Varin, F., Villagra, V., Colindres, R. and Powell, J.R.: Mechanism of the vasodilatory effect of carvedilol in normal volunteers: A comparison with labetalol. Int. Soc. of Hypertension, Aug. 1986. 89. Cubeddu, L.X. and Hoffmann, I.S.: Cerebrospinal fluid norepinephrine levels in essential hypertension: Effects of drug treatment and withdrawal. Int. Soc. of Hypertension, Aug. 1986. 90. Powell, J.R., Lahey, A., Villagra, V.G. and Cubeddu, L.X.: Carvedilol pharmacokinetics after two intravenous doses. Int. Soc. of Hypertension, Aug. 1986. 91. Diliberto, P.A. and Cubeddu, L.X.: The effects of chloride substitution on spontaneous dopamine efflux and electrically-evoked release of dopamine and acetylcholine in superfused striatal slices. Soc. for Neuroscience, Nov. 1986. 92. Cubeddu, L.X. and Diliberto, P.A.: The effect of chloride substitution on agonist induced autoreceptor activation in superfused striatal slices. Soc. for Neuroscience, Nov., 1986. 93. Parker, E.M. and Cubeddu, L.X.: The effect of dopamine (DA) synthesis inhibition on dopaminergic neurotransmission in rabbit striatal slices. Soc. for Neuroscience, Nov. 1986. 94. Talmaciu, R.K., Hoffmann, I.S. and Cubeddu, L.X.: Dopamine release from rabbit prefrontal cortex is modulated by D2 dopamine autoreceptors. Soc. for Neuroscience, Nov. 1986. 95. Cubeddu, L.X.: New alpha blocking agents. Am. College of Clin. Pharmacol., Oct. 1986, Main Lecture. 96. Fuenmayor, N. and Cubeddu, L.X.: Comparative pharmacodynamics and kinetics of slow-release (SR) and immediate release (IR) verapamil under fed and fasting states in essential hypertension. Amer. Soc. Hypert., May 1987. 97. Zubieta, J.K. and Cubeddu, L.X.: Effects of amiloride on dopaminergic and cholinergic mechanisms. Amer. Soc. Hypert., May 1987. 98. Cubeddu, L.X., Pool, J.L., Bloomfield, R., Pickering, B.I., Klotman, P.E., Wombolt, D.G., Halperin, A. and Nelson, E.B.: Once a day doxazosin monotherapy for the treatment of essential hypertension: effects of serum lipids. Amer. Soc. Hypert., May 1987. 24
LUIGI X. CUBEDDU 99. Hoffmann, I.S., Ferro, C.P., Talmaciu, R.K. and Cubeddu, L.X.: Modulation of dopamine release from mesocortical neurons. Int. and Amer. Soc. Neurochemistry, June 1987. 100. Cubeddu, L.X., Hoffmann, I.S., Suarez-Roca, H., Talmaciu, R.K. and Lovenberg, T.: Acetylcholine release as a marker for postsynaptic dopamine effects in striatal, limbic and prefrontal regions. Int. and Amer. Soc. Neurochemistry, June 1987. 101. Diliberto, P.A., and Cubeddu L.X.: Non-vesicular release of dopamine from uperfused striatal slices is induced by low chloride medium with subsequent inhibition of electrically stimulated acetylcholine and dopamine release. Int. and Amer. Soc. Neurochemistry, June 1987. 102. Cubeddu, L.X.: Indirect effects of amphetamine and related amines on dopaminergic neurons: ionic mechanisms. 6th Int. Catecholamine Sym., June 1987. 103. Cubeddu, L.X. and Parker, E.M.: Dopamine intraneuronal pools and mechanisms by which amphetamine increases dopamine efflux from dopaminergic neurons. 6th Int. Catecholamine Sym., June 1987. 104. Cubeddu, L.X., Talmaciu, R.K., Suarez-Roca, H. and Hoffmann, I.S.: Modulation of dopamine release from striatal, limbic and cortical brain regions: dopamine-acetylcholine interactions. Int. Congress of Pharmacology, Aug. 1987. 105. Suarez-Roca, H. and Cubeddu, L.X.: Interactions between dopamine and acetylcholine in the olfactory tubercle and nucleus caudate. Soc. for Neurosci., Nov. 1987. 106. Fuenmayor, N. and Cubeddu, L.X.: Niveles plasmaticos de verapamil en pacientes hipertensos que reciben tratamiento con verapamil de liberacion inmediata y de liberacion prolongada. VII Congreso Latinoamericano de Nefrologia, May 1988 107. Fuenmayor, N. and Cubeddu, L.X.: Efecto antihipertensivo sobre la conduccion auriculoventricular y efectos secundarios del verapamil de liberacion inmediata (LI) y de liberacion prolongada (LP) en pacientes hipertensos. VII Congreso Latinoamericano de Nefrologia, May 1988 108. Cubeddu, L.X., Buckley, J., Hedner T., Massotto, C. and Negro Vilar, A. Changes in atrial natriuretic peptides (ANP), arginine vasopressin (AVP), renin activity (PRA), angiotensin II (A (() and aldosterone (ALD) induced by calcium channel blockers and acute volume expansion. Am. Soc. Hypertension, July 1988. 109. Williams, D.M. and Cubeddu, L.X. Amlodipine pharmacokinetics in healthy volunteers. Am. Soc. Hypertension, July 1988. 110. Lovenberg, T.W., Diliberto, P.A. and Cubeddu, L.X. Dopamine receptor control of 3H-dopamine and 14Cacetylcholine release: effects of phorbol ester and forskolin. Society for Neuroscience, 14:1093, l988. 111. Talmaciu, R.K., Hoffmann, I.S., Calvo,R., Aquino, R. and Cubeddu, L.X. Prefrontal cortex (PFC) and striatum (S) dopamine (DA) terminals: difer sensitivity to calcium depolarizing stimuli and K+ conductance inhibitors. III Congress of Interamerican Pharmacology and Clinical Therapeutics, 1988. 112. Hoffmann, I.S., Talmaciu, R.K., Calvo, R., Aquino, R. and Cubeddu, L.X. Differential activation of protein kinase C (PKC) by phorbol esters (Pu) in prefrontal cortex (PFC) and striatal (S) dopamine (DA) neurons. III Congress of InterAmerican Pharmacology and Clinical Therapeutics, 1988. 113. Fuenmayor, N., Faggin, B.M. and Cubeddu, L.X. Pharmacokinetics of verapamil in essential hypertension: effects of food intake. III Congress of Interamerican Pharmacology and Clinical Therapeutics, 1988. 25
Page 1 and 2: PERSONAL: Name: Luigi Cubeddu CURRI
Page 3 and 4: LUIGI X. CUBEDDU 1971 - 1974 Teachi
Page 5 and 6: LUIGI X. CUBEDDU 1984 - 1986 Lectur
Page 7 and 8: LUIGI X. CUBEDDU AWARDS AND HONORS
Page 9 and 10: LUIGI X. CUBEDDU 17.Pinardi, G. and
Page 11 and 12: LUIGI X. CUBEDDU 50. Fuenmayor, N.
Page 13 and 14: LUIGI X. CUBEDDU 83.Faggin, B.M., Z
Page 15 and 16: LUIGI X. CUBEDDU 116. Fuenmayor, N.
Page 17 and 18: LUIGI X. CUBEDDU 145. Tristano A, C
Page 19 and 20: LUIGI X. CUBEDDU PRESENTATIONS AT S
Page 21 and 22: LUIGI X. CUBEDDU 34. Cubeddu, L.X.
Page 23: LUIGI X. CUBEDDU 64. Hoffmann, I.S.
Page 27 and 28: LUIGI X. CUBEDDU 127. Cubeddu, L.X.
Page 29 and 30: LUIGI X. CUBEDDU 157. Castejon AM,
Page 31 and 32: LUIGI X. CUBEDDU 186. Castejon AM,
Page 33 and 34: LUIGI X. CUBEDDU 215. Cubeddu L.X,
Page 35 and 36: LUIGI X. CUBEDDU 243. Guevara, BH,
Page 37 and 38: LUIGI X. CUBEDDU 270. Jiménez-Vale
Page 39 and 40: LUIGI X. CUBEDDU BOOK CHAPTERS 1. G

CURRICULUM VITAE Luigi Cubeddu PERSONAL - College of ...

Create successful ePaper yourself

Delete template?

Save as template?